<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01681875</url>
  </required_header>
  <id_info>
    <org_study_id>U54DA031659</org_study_id>
    <secondary_id>U54DA031659-01</secondary_id>
    <nct_id>NCT01681875</nct_id>
  </id_info>
  <brief_title>Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes</brief_title>
  <acronym>P1S1</acronym>
  <official_title>Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Masonic Cancer Center, University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Minnesota, MN</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Project 1, Study 1 will evaluate the relationship between nicotine yield of very low nicotine
      content cigarettes and cigarettes smoked per day, nicotine exposure, discomfort/dysfunction,
      other health-related behaviors, nicotine/tobacco dependence, biomarkers of tobacco exposure,
      intention to quit, compensatory smoking, other tobacco use, cigarette characteristics,
      cognitive function, cardiovascular function, and perceived risk. We will also consider
      differences between conditions in compliance with product use.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of cigarettes smoked per day</measure>
    <time_frame>End of 6 week intervention</time_frame>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">839</enrollment>
  <condition>Tobacco Dependence</condition>
  <arm_group>
    <arm_group_label>0.8 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>very low nicotine content cigarettes
SPECTRUM Cigarette: 0.8 (±0.15) mg nicotine with 9 (±1.5) mg tar (standard nicotine and tar yields of commercially-available cigarettes; control condition)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.26 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>very low nicotine content cigarettes
SPECTRUM Cigarette: 0.26 (±0.06) mg nicotine with 9 (±1.5) mg tar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.12 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>very low nicotine content cigarettes
SPECTRUM Cigarette: 0.12 (±0.03) mg nicotine with 9 (±1.5) mg tar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.07 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>very low nicotine content cigarettes
SPECTRUM Cigarette: 0.07 (±0.02) mg nicotine with 9 (±1.5) mg tar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.03 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>very low nicotine content cigarettes
SPECTRUM Cigarette: 0.03 (±0.01) mg nicotine with 9 (±1.5) mg tar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.04 mg nicotine with 13 mg tar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>very low nicotine content cigarettes
SPECTRUM Cigarette: 0.04 (±0.02) mg nicotine with 13 (±2) mg tar</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual brand</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>very low nicotine content cigarettes
Usual brand cigarettes (control condition)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>very low nicotine content cigarettes</intervention_name>
    <arm_group_label>0.8 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_label>0.26 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_label>0.12 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_label>0.07 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_label>0.03 mg nicotine with 9 mg tar</arm_group_label>
    <arm_group_label>0.04 mg nicotine with 13 mg tar</arm_group_label>
    <arm_group_label>Usual brand</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18+

          -  Smoke an average of at least five cigarettes per day for at least 1 year

          -  Breath CO levels &gt; 8 ppm (if ≤ 8 ppm, then NicAlert Strip &gt; 2)

        Exclusion Criteria:

          -  Intention to quit smoking in the next 30 days

          -  Currently seeking treatment for smoking cessation

          -  Currently using nicotine replacement therapies or other pharmacotherapies as cessation
             aid (intermittent use acceptable)

          -  A quit attempt in the past 30 days resulting in greater than 3 days of abstinence

          -  Using other tobacco products more than 9 days in the past 30 days

          -  Significant unstable medical conditions (Any significant change in a serious medical
             condition occurring during the past 3 months including, cardiovascular disease, COPD,
             and cancer, as determined by the licensed medical professional at each site)

          -  Significant unstable psychiatric conditions (Any significant change in psychiatric
             symptoms during the past 3 months as determined by the licensed medical professional
             at each site)

          -  Schizophrenia and schizoaffective disorder

          -  Psychiatric medication changes in the past 3 months

          -  Positive toxicology screen for any of the following drugs: cocaine, opiates,
             methadone, benzodiazepines, barbiturates, amphetamines, methamphetamines, and PCP

               1. Marijuana will be tested for but will not be an exclusionary criterion.

               2. Participants with valid prescriptions for opiates, benzodiazepines, barbiturates,
                  amphetamines or methadone will not be excluded.

               3. Participants failing the toxicology screen will be allowed to re-screen once.

          -  Blood alcohol level &gt; 0.01

             a. Participants failing the blood alcohol screen will be allowed to re-screen once.

          -  Binge drinking alcohol (more than 9 days in the past 30 days, 4/5 in a 2 hour
             period(female/male))

          -  Pregnant or breastfeeding

          -  Smoking 'roll your own cigarettes' exclusively

          -  Currently taking anticonvulsant medication

          -  CO reading &gt;80 ppm

          -  Systolic BP greater than or equal to 160

             a. Participants failing for blood pressure will be allowed to re-screen once.

          -  Diastolic BP greater than or equal to 100

             a. Participants failing for blood pressure will be allowed to re-screen once.

          -  Systolic BP below 90

             a. Participants failing for blood pressure will be allowed to re-screen once.

          -  Diastolic BP below 50

             a. Participants failing for blood pressure will be allowed to re-screen once.

          -  Heart rate greater than or equal to 115bpm

             a. Participants failing for heart rate will be allowed to re-screen once.

          -  Heart rate lower than 45bpm

             a. Participants failing for heart rate will be allowed to re-screen once.

          -  Indicating any suicidal ideation in the past month or suicide attempts in the past 10
             years

          -  Inability to independently read and comprehend the consent form and other written
             study materials and measures

          -  Having participated in a research study during the past three months in which the
             participant:

               1. Smoked a cigarette that was not his/her usual brand cigarette for more than one
                  day

               2. Used any tobacco products beyond normal use for more than one day

               3. Used any nicotine replacement products or smoking cessation medications for more
                  than one day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric C Donny, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33617</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical School Duluth</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55812</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Masonic Cancer Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Donny EC, Jones M. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug Alcohol Depend. 2009 Sep 1;104(1-2):23-33. doi: 10.1016/j.drugalcdep.2009.01.021. Epub 2009 May 15.</citation>
    <PMID>19446968</PMID>
  </reference>
  <reference>
    <citation>Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, Allen SS, Shields PG, Murphy SE, Stepanov I, Hecht SS. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction. 2010 Feb;105(2):343-55. doi: 10.1111/j.1360-0443.2009.02780.x.</citation>
    <PMID>20078491</PMID>
  </reference>
  <reference>
    <citation>Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P 3rd. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):761-9. doi: 10.1158/1055-9965.EPI-11-0644. Epub 2012 Feb 21.</citation>
    <PMID>22354905</PMID>
  </reference>
  <reference>
    <citation>Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction. 2007 Feb;102(2):324-34.</citation>
    <PMID>17222288</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2012</study_first_submitted>
  <study_first_submitted_qc>September 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2012</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biomarkers of exposure</keyword>
  <keyword>Compensatory smoking</keyword>
  <keyword>Nicotine dependence</keyword>
  <keyword>Reduced nicotine cigarettes</keyword>
  <keyword>Tobacco withdrawal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

